prokidney.com (PROK) - Year-over-year earnings per share growth for the last twelve months

ProKidney Corp - graphic logo of issuer PROK

The absence of commercial revenue and ongoing R&D expenditures define the current financial profile of ProKidney Corp. (PROK). The quarterly EPS trend reflects this trajectory, with -41.10 recorded as the baseline value. A high-tech cellular ecosystem with a closed-loop REACT tissue production cycle tightly integrates clinics with the company's logistics. The strategy focuses on safety validation and the completion of key trials for US regulators.

ProKidney Corp (PROK) - Earnings per share growth in annualized terms for the last twelve months from 04/28/2023 to 11/14/2026

Analytical breakdowns for ProKidney Pharma (PROK)

- share price and expert price forecast:
Stock Price ProKidney|PROK - Broker Consensus Forecast
- market capitalization indicators:
Market Value ProKidney Inc.|PROK - Business Value
- book capitalization data:
Book Value per Share ProKidney|PROK - Total Stockholders' Equity|Market Cap to Net Assets Ratio prokidney.com|PROK - Company Assets
- debt and solvency information:
Debt to Equity ProKidney Corp.|PROK - Long-Term Liabilities to Equity|Short-Term Debt to Equity ProKidney Corp.|PROK - Aggregate Debt Obligations|Debt to Book Capitalization Ratio ProKidney Inc.|PROK - Long-Term Debt|Company Short-Term Debt ProKidney|Quick Ratio prokidney.com
- earnings and valuation multiples indicators:
PROK - Net Financial Result|Projected Future Earnings ProKidney Corp.|PROK - Price to Earnings Multiple|Future Price to Earnings ProKidney Inc.|PROK - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple ProKidney Inc.|PROK - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months ProKidney|PROK - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months prokidney.com|PROK - Earnings per share increase in current year|Earnings growth forecast for next year ProKidney Corp.
- sales volume and revenue indicators:
PROK - Company Sales|Company Projected Revenue ProKidney|PROK - Price to Sales|Price-to-Projected Revenue Ratio ProKidney Inc.
Summary company analytics:ProKidney Corp.
Manufactured product of ProKidney Corp.

This indicator measures the quarterly dynamics of earnings per share (EPS). It allows for an assessment of the actual capital growth rate and the business's sensitivity to market fluctuations. By analyzing the quarterly EPS growth chart, an investor can determine the efficiency of resource management. For ProKidney Corp. (PROK), such data reflects the cost of intensive R&D for the REACT platform. Negative values here are expected when scaling breakthrough cellular technologies.

Analysis of competing companies

TVTX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ARDX|Year-over-year earnings per share growth for the last twelve months Akebia|Year-over-year earnings per share growth for the last 12 months TVRD (Cara Corp)|Quarterly EPS earnings growth DMAC|UNCY - Earnings per share growth in annualized terms for the last twelve months|Rockwell Medical, Inc. - Year-over-year net earnings per share growth for the last 12 months|Cadrenal Therapeutics Inc. (CVKD) - Earnings per share growth in annualized terms for the last twelve months|CDT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months CALT|renalytix.com (RNLX) - Year-over-year earnings per share growth for the last twelve months|ZyVersa Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months